@misc{indiciae134dfa3fffcd,
  title = {Targeting regulatory T cells with Interleukin-2 treatment in type 1 diabetes: a response-adaptive, non-randomised, open-label trial of repeat doses of Aldesleukin (DILfrequency)},
  author = {Seelig, E. and Howlett, J. and Porter, L. and Truman, L. and Heywood, J. and Kennet, J. and Arbon, E. L. and Anselmiova, K. and Walker, N. M. and Atkar, R. and Pekaiski, M. L. and Rytina, E. and Evans, M. and Wicker, L. S. and Todd, J. A. and Mander, A. P. and Bond, S. and Waldron-Lynch, F.},
  year = {2017},
  doi = {10.1101/223958},
  url = {https://www.biorxiv.org/content/10.1101/223958v1},
  note = {Source identifier: 10.1101/223958}
}